title: Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock.
abstract: Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Westchester Medical Center, 100 Woods Rd, Valhalla, NY, 10595, USA.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Furqan
authors.forename: Yamei
authors.initials: Y
authors.lastname: Chen
authors.forename: Akintunde
authors.initials: A
authors.lastname: Akinleye
authors.forename: Judy
authors.initials: J
authors.lastname: Sarungbam
authors.forename: Alan
authors.initials: A
authors.lastname: Gass
authors.forename: Karen
authors.initials: K
authors.lastname: Seiter
authors.forename: Delong
authors.initials: D
authors.lastname: Liu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D012770:Shock, Cardiogenic / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents